Sana Biotechnology (SANA) News Today → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free SANA Stock Alerts $9.27 +0.67 (+7.79%) (As of 05:13 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 6:52 PM | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Up 9.1%Sana Biotechnology (NASDAQ:SANA) Shares Up 9.1%May 13 at 6:52 AM | americanbankingnews.comSana Biotechnology (NASDAQ:SANA) Earns Buy Rating from HC WainwrightMay 10, 2024 | finance.yahoo.comSana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial ResultsMay 9, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Given "Buy" Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $12.00 price objective on shares of Sana Biotechnology in a research report on Thursday.May 9, 2024 | markets.businessinsider.comSana Biotechnology: Promising Clinical Studies and Breakthrough Potential in T1D TherapyMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Sana Biotechnology Amidst Strong Clinical Progress and Solid FinancialsMay 8, 2024 | investorplace.comSANA Stock Earnings: Sana Biotechnology Meets EPS for Q1 2024May 8, 2024 | sfgate.comSana: Q1 Earnings SnapshotMay 8, 2024 | finance.yahoo.comSana Biotechnology Reports First Quarter 2024 Financial Results and Business UpdatesMay 6, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Down 4% Sana Biotechnology (NASDAQ:SANA) Stock Price Down 4%May 6, 2024 | globenewswire.comSana Biotechnology to Present at May and June 2024 Investor ConferencesMay 2, 2024 | finance.yahoo.comNvelop Therapeutics Announces Members of Its Scientific Advisory BoardMay 1, 2024 | finance.yahoo.comSana Biotechnology, Inc. (SANA) Stock Price, News, Quote & History - Yahoo FinanceApril 26, 2024 | msn.comTech Moves: Seattle tech vet Dave Parker named CEO of Entrepreneurs’ OrganizationApril 25, 2024 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Mirae Asset Global Investments Co. Ltd.Mirae Asset Global Investments Co. Ltd. boosted its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 286.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 197,386 shares of the company's stock after aApril 24, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Trading Up 5.3%Sana Biotechnology (NASDAQ:SANA) Trading 5.3% HigherApril 22, 2024 | bizjournals.comSana Biotechnology R&D leader Douglas Williams steps downApril 20, 2024 | investing.comSana Biotechnology EVP Williams resigns from R&D postApril 18, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 3.8%Sana Biotechnology (NASDAQ:SANA) Shares Down 3.8%April 5, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Trading 3.5% Higher Sana Biotechnology (NASDAQ:SANA) Trading Up 3.5%April 2, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Gap Down to $10.12Sana Biotechnology (NASDAQ:SANA) Shares Gap Down to $10.12March 17, 2024 | seekingalpha.comSana Biotechnology: Now In Overbought TerritoryMarch 16, 2024 | finance.yahoo.comSANA Apr 2024 15.000 callMarch 14, 2024 | finance.yahoo.comJ&J, Novo support Asgard’s push to make ‘in vivo’ cell therapiesMarch 14, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 5.6%Sana Biotechnology (NASDAQ:SANA) Trading Down 5.6%March 14, 2024 | marketbeat.comPublic Sector Pension Investment Board Decreases Stake in Sana Biotechnology, Inc. (NASDAQ:SANA)Public Sector Pension Investment Board lowered its position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 69.6% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,635,514 shares of the company's stock after selling 3,735,779 shares duMarch 11, 2024 | finance.yahoo.comDirector Patrick Yang Sells 25,000 Shares of Sana Biotechnology Inc (SANA)March 9, 2024 | marketbeat.comTrexquant Investment LP Purchases Shares of 136,426 Sana Biotechnology, Inc. (NASDAQ:SANA)Trexquant Investment LP bought a new stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 136,426 shares of the company's stock, valued at appMarch 7, 2024 | finance.yahoo.comBaillie Gifford Bolsters Stake in Sana Biotechnology IncMarch 7, 2024 | marketbeat.com540,250 Shares in Sana Biotechnology, Inc. (NASDAQ:SANA) Acquired by GSA Capital Partners LLPGSA Capital Partners LLP bought a new position in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 540,250 shares of the company's stock, valued at approximately $2,091,000. GSA CaMarch 3, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Gap Up on Better-Than-Expected EarningsSana Biotechnology (NASDAQ:SANA) Shares Gap Up Following Earnings BeatMarch 1, 2024 | markets.businessinsider.comSana Biotechnology: Buy Rating Affirmed Amid Anticipation of Clinical Breakthroughs and Hypoimmune Platform ValidationMarch 1, 2024 | markets.businessinsider.comSana Biotechnology: Promising Clinical Prospects and Buy Rating Justified by Upcoming Data ReadoutsMarch 1, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Issues Earnings ResultsSana Biotechnology (NASDAQ:SANA - Get Free Report) announced its earnings results on Thursday. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.38) by $0.03. During the same quarter in the prior year, the company earned ($0.40) earnings per share.March 1, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Price Target Increased to $15.00 by Analysts at JMP SecuritiesJMP Securities increased their price target on Sana Biotechnology from $8.00 to $15.00 and gave the stock a "market outperform" rating in a research report on Friday.March 1, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Gap Up After Earnings BeatSana Biotechnology (NASDAQ:SANA) Shares Gap Up Following Better-Than-Expected EarningsMarch 1, 2024 | marketbeat.comFmr LLC Sells 745,336 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Fmr LLC decreased its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 4.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,898,729 shares of the company's stock after selling 745,33March 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA) and Sana Biotechnology (SANA)February 29, 2024 | globenewswire.comSana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesFebruary 28, 2024 | globenewswire.comSana Biotechnology to Present at the Cowen 44th Annual Health Care ConferenceFebruary 19, 2024 | finance.yahoo.comInstitutional investors are Sana Biotechnology, Inc.'s (NASDAQ:SANA) biggest bettors and were rewarded after last week's US$521m market cap gainFebruary 18, 2024 | 247wallst.comInsider Buying: Taking a Controlling Stake in a Struggling Retailer?February 16, 2024 | marketbeat.comBaillie Gifford & Co. Sells 631,786 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)Baillie Gifford & Co. cut its position in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 5.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,204,375 shares of the company's stock afterFebruary 13, 2024 | finance.yahoo.comSana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHPFebruary 13, 2024 | marketbeat.comHarvard Management Co. Inc. Lowers Stock Holdings in Sana Biotechnology, Inc. (NASDAQ:SANA)Harvard Management Co. Inc. cut its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 53.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 216,376 shares of the company's stock after selling 252,373 shares during the period. Sana BiotechnoFebruary 13, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Up 2.2% Following Insider Buying ActivitySana Biotechnology (NASDAQ:SANA) Trading 2.2% Higher on Insider Buying ActivityFebruary 12, 2024 | finance.yahoo.comSana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesFebruary 12, 2024 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Down 2.2% Sana Biotechnology (NASDAQ:SANA) Shares Down 2.2%February 9, 2024 | msn.comSana Biotechnology Announces Pricing of Upcoming OfferingFebruary 9, 2024 | msn.comSana Biotechnology’s Major Public Offering Agreement Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company SANA Media Mentions By Week SANA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SANA News Sentiment▼0.390.55▲Average Medical News Sentiment SANA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SANA Articles This Week▼122▲SANA Articles Average Week Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: APGE News Today CGON News Today KYMR News Today RXRX News Today VCEL News Today DNA News Today DNLI News Today TWST News Today BEAM News Today FUSN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SANA) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
